Profilo
Scott A.
Young is currently the Head-Investor Relations at Invivyd, Inc. He previously worked as the VP-Corporate Communications & Investor Relations at Flexion Therapeutics, Inc. from 2018 to 2022.
Posizioni attive di Scott A. Young
| Società | Posizione | Inizio |
|---|---|---|
| INVIVYD, INC. | Contatto Relazioni con gli Investitori | 01/08/2023 |
Precedenti posizioni note di Scott A. Young
| Società | Posizione | Fine |
|---|---|---|
| FLEXION THERAPEUTICS, INC. | Contatto Relazioni con gli Investitori | 01/02/2022 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| INVIVYD, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand, an extended-release corticosteroid approved to manage osteoarthritis knee pain. The company was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA. | Health Technology |
- Borsa valori
- Insiders
- Scott A. Young
